Thyroid C-cell hyperplasia in an adolescent with neurofibromatosis type 1

Horm Res. 2001;56(1-2):63-6. doi: 10.1159/000048092.

Abstract

Background: Subjects with neurofibromatosis type 1 (NF1) show an increased risk of endocrine tumors, especially pheochromocytoma, whereas thyroid C-cell hyperplasia (CCH) and medullary thyroid carcinoma (MTC) are very rare events described only in adult patients.

Method: A case of CCH diagnosed in a 14-year-old girl affected with NF1 is reported. Calcitonin serum level after pentagastin was elevated (286 pg/ml). Genetic testing was performed in order to rule out mutations in the RET proto-oncogene.

Result: No germline mutation previously reported in MEN2 was detected. Multifocal and bilateral CCH was demonstrated by immunohistochemistry.

Conclusion: It is suggested that in such a genetic background of high risk for malignancy, CCH could be considered as an extremely rare condition likely preceding MTC.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Female
  • Humans
  • Hyperplasia
  • Immunohistochemistry
  • Neurofibromatosis 1 / pathology*
  • Proto-Oncogene Mas
  • Thyroid Gland / pathology*